Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

New scale reliably assesses male hair loss with female pattern.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Nearly all elderly nursing home residents had a skin disease, with dry skin being the most common.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Reducing copper (II) ion levels in hair can decrease hair damage.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Women with PCOS have lower amylin levels, which are not related to their body weight.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

Saw palmetto helps with nighttime urination and urine flow, similar to finasteride.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Premature graying of hair is linked to vitamin D and B12 deficiencies, thyroid issues, iron imbalance, stress, and lifestyle habits, and affects quality of life.

Post-bariatric surgery patients often face gastrointestinal issues, fatigue, dry skin, hair loss, and anxiety.

The document is a detailed medical reference on skin and genetic disorders.

Low-level laser therapy combined with Neoptide improved hair regrowth better than either treatment alone in rats.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.